About the research group
Tumor Angiogenesis group is a research group in the ProCURE Program and OncoBell Program from the Bellvitge Biomedical Research Institute (IDIBELL) and Catalan Institute of Oncology (ICO), with a particular interest in mechanisms of antiangiogenic resistance and of metastasis. We are an enthusiastic team focused on understanding how we can efficiently discover new targets and treatments for metastasis or for treatment-resistant cancer patients.
About the role
We are seeking a highly motivated candidate who wants to join our team to perform his/her doctoral thesis and develop his/her career in a cancer research laboratory. The candidate will join our group with an FPI contract and salary to develop our PID-MICIN project entitled "Dissection of Platelets and Coagulation genes’ mechanisms in Kidney Cancer Metastasis (PlaCoMets)".
Job requirements
Practical experience
- Laboratory experience of several months (TFG, TFM or more)
- Experience in cellular and molecular biology, cell culture and animal models
Education and training
- Masters in Biosciences (cancer, biomedicine, biotech, biology, human genetics...)
- Accredited in Animal Experimentation (preferred)
Technical & soft skills
- Excellent analytical and problem-solving skills
- Good listener, fast learner with exceptional ability to understand and simplify complex problems
- Relevant interpersonal skills with the ability to develop effective relationships with project team members
Languages
We will value, but not required
-
Laboratory experience beyond Master's lab stay (TFM)
-
Experience in animal models of cancer, transgenics or PDX
-
Laboratory techniques to value: flow cytometry, confocal microscopy, advanced cell culture
What do we offer
-
No. of positions: 1
-
Estimated start date: Octobre or November 2023
-
Contract duration: 4 years
-
Estimated annual gross salary: 17.650 €
-
You will be part of a multicultural team. We have a fun loving and friendly international work environment.
-
Flexible working schedule -We know you have a life outside of work and we will work with you to make sure it's kept that way.
-
Possibility to work some days in remote -Teleworking
-
26 working days of holiday per year
-
System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.
-
Paid leave package
-
Benefits of constant training are offered.
-
We offer and promote diverse and inclusive condition. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.
Deadline: Please submit your application by 18/09/2023
Data protection notice
In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate.
You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.
Our institute
IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.
Observations:
The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).
IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).
